Reuben Clark Law School, Brigham Young University, J.D., magna cum laude, 1996
Utah State University, B.A., cum laude, 1993
District of Columbia Bar
State Bar of California
State Bar of New York
U.S. District Court for the District of Columbia
U.S. District Court for the Central District of California
U.S. District Court for the Northern District of California
U.S. District Court for the Southern District of California
U.S. Courts of Appeals for the Fifth Circuit
U.S. Courts of Appeals for the Ninth Circuit
U.S. Court of Appeals for the Federal Circuit
U.S. Court of Federal Claims
Jon Corey represents companies, health systems, healthcare providers, and state attorneys general as plaintiffs in high-stakes affirmative recovery litigation, including antitrust actions and claims against the nation’s largest health insurers. He has recovered more than $25 billion for clients over the course of his career. What sets Jon apart is his ability to find claims his clients had not recognized, quantify their value, build the theory of the case, and lead the matter through resolution.
Self-funded plan sponsors, for example, often have little visibility into how the insurers administering their plans handle plan assets. Jon uncovers the overcharges, conflicts, and self-dealing within that administration, and has prosecuted ERISA fiduciary claims on behalf of Fortune 50 and Fortune 100 companies. In one of those matters, he secured an eight-figure settlement before a complaint was filed. He also represented whistleblowers in an action that, after the New Jersey Attorney General intervened, produced a $100 million settlement from Horizon Blue Cross Blue Shield of New Jersey for the State of New Jersey.
In his antitrust practice, Jon represents more than 20 companies and dozens of health systems that opted out of the subscriber and provider settlements in In re Blue Cross Blue Shield Antitrust Litigation. He also represents dozens of out-of-network surgical practices in algorithmic price-fixing claims against MultiPlan (now Claritev) and major commercial insurers, and a set of corporate clients against the major pharmacy benefit managers and primary insulin manufacturers in the insulin price-fixing multidistrict litigation. His antitrust work extends well beyond health care, including claims against a trade association that used sham certification standards to exclude a manufacturer from the national market.
Jon has also brought RICO, trade secret, intellectual property, securities, environmental and business tort claims for companies, unions, government entities and individuals across industries. He was trial counsel for the Federal Housing Finance Agency (FHFA) in its landmark RMBS litigation arising from the conservatorship of Fannie Mae and Freddie Mac. That work included the $800 million judgment against Nomura and RBS in the Southern District of New York, which the Second Circuit affirmed.
Over the course of his career, Jon has represented:
Health Care Payer Litigation
Whistleblowers in a qui tam action alleging that Horizon Blue Cross Blue Shield of New Jersey submitted false claims for funding from the New Jersey State Health Benefits Plan; worked closely with the New Jersey Attorney General through its investigation and decision to intervene, resulting in a $100 million settlement for the State of New Jersey.
More than 20 companies that opted out of the $2.7 billion subscriber settlement in In re Blue Cross Blue Shield Antitrust Litigation, in claims alleging that the Blue Cross Blue Shield Association and its member plans unlawfully divided territories in violation of federal antitrust law.
Dozens of health systems and health care providers that opted out of the $2.8 billion provider settlement in In re Blue Cross Blue Shield Antitrust Litigation.
Dozens of out-of-network surgical practices in price-fixing claims against MultiPlan, Inc., (now Claritev) its affiliates and major commercial health insurers, alleging a scheme to depress what surgeons are paid for treating insured patients.
Several state Attorneys General in investigating and prosecuting claims against commercial health insurers for breach of contract, breach of fiduciary duty, and violations of state antitrust law.
ERISA Claims for Self-Funded Plan Sponsors
A Fortune 100 company in claims that the insurer administering its self-funded health benefits plans breached statutory and common law fiduciary duties and engaged in prohibited transactions; secured an eight-figure settlement before a complaint was filed.
Self-funded plan sponsors, including a Fortune 50 company and major companies in financial services, technology, chemicals, food service, consumer food products, utilities and health care, in ERISA fiduciary breach, self-dealing and prohibited transaction claims against the health insurers administering their plans.
A government sponsor of a self-funded health benefits plan in claims against a Blue Cross Blue Shield licensee over its administration of the plan.
Government and Financial Institution Litigation
The Federal Housing Finance Agency (FHFA), as conservator for Fannie Mae and Freddie Mac, in landmark RMBS litigation against UBS, JPMorgan, Merrill Lynch, Citibank, Goldman Sachs, Barclays, Bank of America and other major banks; served as trial counsel in the SDNY trial against Nomura and RBS that resulted in an $800 million judgment, affirmed by the Second Circuit.
Antitrust, RICO and Unfair Competition
A construction products manufacturer in antitrust and RICO claims against a trade association and its members, which adopted sham certification standards in an attempt to exclude the manufacturer’s products from the national market.
An oil exploration company in antitrust claims alleging that a Fortune 100 corporation interfered with its efforts to compete for oil and gas exploration rights in the Timor Sea.
Trade Secrets, IP and Commercial Disputes
A packaging company in patent infringement litigation; won summary judgment of infringement on two patents, leading to an immediate settlement of more than $23 million.
A software publisher in claims that a foreign heavy equipment manufacturer improperly accessed, infringed and misappropriated its source code, and in defending counterclaims over the software’s implementation.
An investment management firm in claims against key employees who systematically downloaded its proprietary analytics software and decades of client and performance data before leaving to start a competing firm.
Industrial and consumer products manufacturers in trade secret theft and RICO claims against former employees and competitors, including a foreign competitor.
A private equity firm and its primary investor in fiduciary breach claims against former officers of the firm’s investment funds.
An acquirer in claims that the seller misrepresented and concealed material accounting information about the target’s financial performance.
A real estate developer in a dispute with a joint venture partner over its failure to adequately supervise construction; obtained a multimillion-dollar settlement.
Lawdragon, 500 Leading Plaintiff Financial Lawyers, 2023-26